Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeBreast ImagingSirius Medical Launches Pintuition System With GPSDetect™ For Precise Navigation In Oncology...

Sirius Medical Launches Pintuition System With GPSDetect™ For Precise Navigation In Oncology Surgery

An affordable and reliable innovative solution that uses state-of-the-art multi-sensor array technology for pinpoint navigational accuracy in all cases

medical specialists, subscribe, medical device news magazine

Sirius Medical, a leader in tumor localization technology, introduces the latest version of the Sirius Pintuition® system powered by a state-of-the-art navigation software, GPSDetect™.

The advanced software provides real-time, directional guidance using audio and visual feedback for unmatched precision to locate tumors, enabling surgeons to navigate to the tumor more easily and precisely. The Pintuition platform with GPSDetect will be revealed at the upcoming 40th European Society of Surgical Oncology (ESSO) Conference in Lisbon, Portugal.

“Our latest GPSDetect software uses our unique multi-sensor technology to provide surgeons unmatched guidance and accuracy,” says Bram Schemers, CEO Sirius Medical. “Pintuition is highly intuitive and our TargetLOC feature provides additional visual feedback to the operator when the probe is perfectly aligned above the seed.”

The Sirius Pintuition system is a state-of-the-art navigation technology for the treatment of non-palpable breast cancer and other soft tissue tumor types. The new system, enhanced by GPSDetect and TargetLOC, delivers a better alternative to surgeons by offering an easy-to-use and reusable detection system that needs only a single calibration per procedure, is highly robust, and cannot be de-activated or lose its signal. Surgeons, radiologists, and staff can easily learn the technology, and it replaces current localization procedures without additional adoption investments.

“The GPSDetect software provides many advantages,” says breast surgical oncologist Irma den Hoed of ETZ hospital in Tilburg, the Netherlands. “Having both visual and audio directional feedback provides perfect navigation towards the tumor and allows me to perform an optimal oncoplastic lumpectomy while significantly improving and simplifying the surgical procedure.”

“We are pleased to use Sirius Pintuition with GPSDetect for targeted soft tissue surgery,” says breast surgical oncologist Isabel Rubio, Breast unit Clinica Universidad de Navarra, Madrid Spain. “The updated software greatly improves localization in breast cancer surgery and is easier and more accurate to use. We look forward to partnering with Sirius Medical to train more surgical oncologists on localization techniques for guided breast cancer surgery.”

“Sirius Pintuition provides precise and directional navigation towards small, non-palpable lesions,” says surgical oncologist Riccardo Giovanazzi, Head Breast Cancer Surgery and Director Breast Unit San Gerardo Hospital, Monza, Italy. “It is very competitive with other technologies supporting surgeons during breast cancer conserving surgery.”

“Sirius Medical has demonstrated they are an innovative company by rapidly responding to surgeons’ needs and producing GPSDetect, which has the promise of providing both distance and navigational guidance for seed localization within the breast and axilla. The iBRA-NET team looks forward to evaluating this technology,” says Mr. Edward St John, Innovation Group Chair for iBRA-NET and Consultant Oncoplastic Breast Surgeon at Portsmouth Hospitals University NHS Trust, UK.

Recently Sirius Medical achieved the milestone of performing over 1,000 procedures for the treatment of non-palpable breast cancers. The Sirius Pintuition system is CE marked and is currently commercially available in Western Europe. The company also expanded operations to the U.S. earlier this year upon receiving FDA clearance.

“We are proud to offer a technology designed by physicians for physicians and are excited about co-creating the future direction of cancer surgery,” says Jan Willem Beijer, Chief Commercial Officer at Sirius Medical. “Sirius Pintuition is helping more physicians precisely and efficiently remove early-stage tumors and provide optimal care for breast cancer patients.”

Movia Robotics Launches Its TheraPal Digital Health Aide with FDA Registration

MOVIA's TheraPal Progress Tracker, TheraPal Home and TheraPal Clinical Assist Aides will be the first of their kind to the market, further cementing MOVIA's mission, innovation, and dedication as an industry leader.

Robocath Successfully Performs 1st Carotid Stenting in France with R-One™ Robot

The procedure is part of a clinical study, which is the first stage of an ambitious research program launched last July by Robocath and Rennes University Hospital, in partnership with Philips France. It aims to enrich the current and future generations of robotic platforms, with the long-term view of improving the treatment of cerebrovascular incidents (CVA, stroke).

Smith+Nephew Announces Digital Surgery & Robotics Innovation Center in Europe

The center will feature a dedicated medical education facility, where surgeons can refine techniques and experience the latest technology through hands-on learning and immersive simulation technology.

Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval

CE Mark approval comes on the heels of major milestones in the Hugo RAS system global launch, including the first urological and gynecological procedures, which took place in Latin America and India and marked the start of the Hugo RAS system global patient registry.

Medtronic Hugo™ Robotic-Assisted Surgery System: 1st Procedure Performed In Asia

The Hugo RAS system — Medtronic's solution to historic cost and utilization barriers that have kept surgical robotics out of reach for many hospitals — is a modular, multi-quadrant platform designed for a broad range of soft-tissue procedures. It combines wristed instruments, 3D visualization, and Touch Surgery™ Enterprise, a cloud-based surgical video capture and management solution, with dedicated support teams specializing in robotics program optimization, service, and training.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

By using this website you agree to accept Medical Device News Magazine Privacy Policy